Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Rooney CM, Huang SH, Su J, Bratman S, Cho J, de Almeida J, Glogauer M, Goldstein D, Hahn E, Hosni A, Hope A, Irish J, Kim J, O'Sullivan B, Ringash J, Spreafico A, Tsai J, Waldron J, Yao C, Watson E, McPartlin A. Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma. Head Neck. 2025 Mar;47(3):847-855. doi: 10.1002/hed.27988. Epub 2024 Oct 30. PubMed PMID: 39474724; PubMed Central PMCID: PMC11816541.
Glicksman RM, Raman S, Ye XY, Bedard PL, Bratman S, Chen E, Chung P, Dawson LA, Hope A, Hosni A, Javor J, Lindsay P, O'Brien C, Wong R, Barry A, Helou J. The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2025 Feb 1;121(2):292-306. doi: 10.1016/j.ijrobp.2024.09.002. Epub 2024 Sep 11. PubMed PMID: 39270828.
Wihlidal J, Esemezie AO, Huang SH, Watson E, Gilbert RW, Waldron J, Gullane PJ, Hope A, Irish JC, O'Sullivan B, Chepeha DB, Kim JJH, Brown D, Cho BCJ, Witterick IJ, Monteiro E, Davies JC, Ringash J, Goldstein DP, Bratman S, Bayley A, de Almeida JR, Chan TCY, Hosni A, Yao CMKL. Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes. Ann Surg Oncol. 2025 Feb;32(2):1270-1279. doi: 10.1245/s10434-024-16385-4. Epub 2024 Oct 28. PubMed PMID: 39467971.
Barghout SH, Meti N, Chotai S, Kim CJH, Patel D, Brown MC, Hueniken K, Zhan LJ, Raptis S, Al-Agha F, Deutschman C, Grant B, Pienkowski M, Moriarty P, de Almeida J, Goldstein DP, Bratman SV, Shepherd FA, Tsao MS, Freedman AN, Xu W, Liu G. Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research. Br J Cancer. 2025 Feb;132(2):139-153. doi: 10.1038/s41416-024-02899-x. Epub 2024 Nov 21. Review. PubMed PMID: 39572762; PubMed Central PMCID: PMC11746990.
Liu G, Huang SH, Ailles L, Rey-McIntyre K, Melton CA, Shen SY, Burgener JM, Brown B, Zhang J, Min J, Wang Y, Hall O, Jones JT, Budhraja K, Provance JB, Sosa EV, Licon A, Williams A, Bratman SV, Allen BA, Zhang J, Hartman AR, De Carvalho DD. Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies. Ann Oncol. 2025 Jan;36(1):108-117. doi: 10.1016/j.annonc.2024.08.2348. Epub 2024 Sep 14. PubMed PMID: 39389887.
Ul Haq S, Downs G, Zhan LJ, Schmid S, Patel D, Sacdalan D, Li JJN, Cheng D, Meti N, Philip V, Kim RH, Liu G, Bratman SV, Sabatini PJB, Lok BH. Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC. JTO Clin Res Rep. 2024 Dec;5(12):100702. doi: 10.1016/j.jtocrr.2024.100702. eCollection 2024 Dec. PubMed PMID: 39564094; PubMed Central PMCID: PMC11574802.
Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B, Ahrens W, Alemany L, Arantes L, Betka J, Bratman SV, Canova C, Conlon M, Conway DI, Cuello M, Curado M, de Carvalho A, de Oliviera J, Gormley M, Hadji M, Hargreaves S, Healy CM, Holcatova I, Hung RJ, Kowalski LP, Lagiou P, Lagiou A, Liu G, Macfarlane GJ, Olshan AF, Perdomo S, Pinto LF, Podesta JV, Polesel J, Pring M, Rashidian H, Gama RR, Richiardi L, Robinson M, Rodriguez-Urrego PA, Santi SA, Saunders DP, Soares-Lima SC, Timpson N, Vilensky M, von Zeidler SV, Waterboer T, Zendehdel K, Znaor A, Brennan P, McKay J, Virani S, Dudding T. Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites. medRxiv. 2024 Nov 18;. doi: 10.1101/2024.11.18.24317473. PubMed PMID: 39606392; PubMed Central PMCID: PMC11601725.
Giuliani ME, Filion E, Faria S, Kundapur V, Toni Vu TTT, Lok BH, Raman S, Bahig H, Laba JM, Lang P, Louie AV, Hope A, Rodrigues GB, Bezjak A, Campeau MP, Duclos M, Bratman S, Swaminath A, Salunkhe R, Warner A, Palma DA. Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET). Int J Radiat Oncol Biol Phys. 2024 Nov 1;120(3):669-677. doi: 10.1016/j.ijrobp.2024.03.050. Epub 2024 Apr 12. PubMed PMID: 38614279.
Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, Virani S, Olshan A, Diergaarde B, Ness AR, Waterboer T, Smith-Byrne K, Brennan P, Hayes DN, Sanderson E, Brown MC, Huang S, Bratman SV, Spreafico A, De Almeida J, Davies JC, Bierut L, Macfarlane GJ, Lagiou P, Lagiou A, Polesel J, Agudo A, Alemany L, Ahrens W, Healy CM, Conway DI, Nygard M, Canova C, Holcatova I, Richiardi L, Znaor A, Goldstein DP, Hung RJ, Xu W, Liu G, Espin-Garcia O. Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 2024 Sep 7;15(1):7835. doi: 10.1038/s41467-024-51679-x. PubMed PMID: 39244563; PubMed Central PMCID: PMC11380676.
Gete M, Huang SH, Ringash J, Irish J, Su J, Ballal Y, Waldron JN, Witterick I, de Almeida J, Hosni A, Hope AJ, Monteiro E, Cho J, O'Sullivan B, Kim J, Bratman S, Goldstein DP, McPartlin A, Tsai J, Tong L, Xu W, Hahn E. Causes and impact of delays during the COVID-19 pandemic on head and neck cancer diagnosis. Head Neck. 2024 Sep;46(9):2197-2205. doi: 10.1002/hed.27784. Epub 2024 Apr 25. PubMed PMID: 38665037.
Hernando-Calvo A, Yang SYC, Vila-Casadesús M, Han M, Liu ZA, Berman AHK, Spreafico A, Razak AA, Lheureux S, Hansen AR, Lo Giacco D, Abbas-Aghababazadeh F, Matito J, Haibe-Kains B, Pugh TJ, Bratman SV, Aleshin A, Berche R, Saavedra O, Garralda E, Elston S, Siu LL, Ohashi PS, Vivancos A, Bedard PL. Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab. JCO Precis Oncol. 2024 Aug;8:e2400100. doi: 10.1200/PO.24.00100. PubMed PMID: 39178369; PubMed Central PMCID: PMC11371115.
Penny L, Main SC, De Michino SD, Bratman SV. Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery. Biochem Cell Biol. 2024 Aug 1;102(4):291-298. doi: 10.1139/bcb-2024-0004. Epub 2024 Mar 13. Review. PubMed PMID: 38478957.
Chepeha DB, Barbon CEA, Esemezie AO, Al Mardini M, Philteos J, Spector ME, Bressmann T, Martino R, Bratman SV, Cho JBC, Hope AJ, Hosni AA, Kim JJH, Ringash JG, Waldron JN, Brown DH, de Almeida JR, Gilbert RW, Goldstein DP, Gullane PJ, Irish JC, Monteiro EA, Yao CMKL. Telemedicine-enabled biofeedback electropalatography rehabilitation (TEBER): A pilot study for patients treated with surgery for oral cavity carcinoma. Head Neck. 2024 Jul;46(7):1737-1751. doi: 10.1002/hed.27721. Epub 2024 Apr 1. PubMed PMID: 38561946.
Stutheit-Zhao EY, Sanz-Garcia E, Liu ZA, Wong D, Marsh K, Abdul Razak AR, Spreafico A, Bedard PL, Hansen AR, Lheureux S, Torti D, Lam B, Yang SYC, Burgener J, Luo P, Zeng Y, Cheng N, Awadalla P, Bratman SV, Ohashi PS, Pugh TJ, Siu LL. Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer Discov. 2024 Jun 3;14(6):1048-1063. doi: 10.1158/2159-8290.CD-23-1060. PubMed PMID: 38393391; PubMed Central PMCID: PMC11145176.
Oliva M, Heirali A, Watson G, Rooney AM, Cochrane K, Jennings S, Taylor R, Xu M, Hosni A, Hope A, Bratman SV, Chepeha D, Weinreb I, Perez-Ordonez B, Nin RM, Waldron J, Xu W, Hansen AR, Siu LL, Coburn B, Spreafico A. Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study. Br J Cancer. 2024 Jun;130(12):1936-1942. doi: 10.1038/s41416-024-02701-y. Epub 2024 May 7. PubMed PMID: 38714747; PubMed Central PMCID: PMC11183079.
de Almeida JR, Martino R, Hosni A, Goldstein DP, Bratman SV, Chepeha DB, Waldron JN, Weinreb I, Perez-Ordonez B, Yu E, Metser U, Hansen AR, Xu W, Su SJ, Kim J. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial. JAMA Otolaryngol Head Neck Surg. 2024 Jun 1;150(6):463-471. doi: 10.1001/jamaoto.2024.0423. PubMed PMID: 38602692; PubMed Central PMCID: PMC11009865.
Sanz-Garcia E, Zou J, Avery L, Spreafico A, Waldron J, Goldstein D, Hansen A, Cho BCJ, de Almeida J, Hope A, Hosni A, Hahn E, Perez-Ordonez B, Zhao Z, Smith C, Zheng Y, Singaravelan N, Bratman SV, Siu LL. Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck. Cell Death Differ. 2024 Apr;31(4):460-468. doi: 10.1038/s41418-024-01272-y. Epub 2024 Feb 26. PubMed PMID: 38409276; PubMed Central PMCID: PMC11043441.
Sarkar S, Chanda A, Khanolkar RA, Lambie M, Ailles L, Bratman SV, Narendran A, Bose P. Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy. Biomedicines. 2024 Feb 23;12(3). doi: 10.3390/biomedicines12030503. PubMed PMID: 38540116; PubMed Central PMCID: PMC10968374.
Han K, Zou J, Zhao Z, Baskurt Z, Zheng Y, Barnes E, Croke J, Ferguson SE, Fyles A, Gien L, Gladwish A, Lecavalier-Barsoum M, Lheureux S, Lukovic J, Mackay H, Marchand EL, Metser U, Milosevic M, Taggar AS, Bratman SV, Leung E. Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer. J Clin Oncol. 2024 Feb 1;42(4):431-440. doi: 10.1200/JCO.23.00954. Epub 2023 Nov 16. PubMed PMID: 37972346; PubMed Central PMCID: PMC10824379.
Murphy T, Zou J, Arruda A, Wang TT, Zhao Z, Zheng Y, Gupta V, Maze D, McNamara C, Minden MD, Schimmer A, Sibai H, Yee K, Capo-Chichi JM, Stockley T, Schuh A, Bratman SV, Chan SM. Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia. Haematologica. 2024 Feb 1;109(2):671-675. doi: 10.3324/haematol.2023.283510. PubMed PMID: 37345484; PubMed Central PMCID: PMC10828788.
Hope A, Kim JW, Kazmierski M, Welch M, Marsilla J, Huang SH, Hosni A, Tadic T, Patel T, Haibe-Kains B, Waldron J, O'Sullivan B, Bratman S. The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):268-274. doi: 10.1016/j.ijrobp.2023.08.018. Epub 2023 Aug 21. PubMed PMID: 37611810.
Watson E, El Maghrabi A, Lee JH, Pu J, Xu W, Joudah S, D'Souza V, Quiñonez C, Mojdami ZD, Huang SH, O'Sullivan B, Ringash J, Kim J, Cho J, Bratman S, Waldron J, Goldstein D, Abdalaty AH, Glogauer M, Hope A. Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients. Oral Oncol. 2023 Oct;145:106527. doi: 10.1016/j.oraloncology.2023.106527. Epub 2023 Jul 25. PubMed PMID: 37499325.
Zeng Y, Ye W, Stutheit-Zhao EY, Han M, Bratman SV, Pugh TJ, He HH. MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis. Bioinformatics. 2023 Jul 1;39(7). doi: 10.1093/bioinformatics/btad423. PubMed PMID: 37402621; PubMed Central PMCID: PMC10348834.
Taylor K, Zou J, Magalhaes M, Oliva M, Spreafico A, Hansen AR, McDade SS, Coyle VM, Lawler M, Elimova E, Bratman SV, Siu LL. Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. Eur J Cancer. 2023 Jul;188:29-38. doi: 10.1016/j.ejca.2023.04.014. Epub 2023 Apr 20. PubMed PMID: 37182343.
Kim JW, Marsilla J, Kazmierski M, Tkachuk D, Huang SH, Xu W, Cho J, Ringash J, Bratman S, Haibe-Kains B, Hope A. Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application. Pract Radiat Oncol. 2023 Jul-Aug;13(4):e354-e364. doi: 10.1016/j.prro.2023.03.003. Epub 2023 Mar 21. PubMed PMID: 36948414.
Kazmierski M, Welch M, Kim S, McIntosh C, Rey-McIntyre K, Huang SH, Patel T, Tadic T, Milosevic M, Liu FF, Ryczkowski A, Kazmierska J, Ye Z, Plana D, Aerts HJWL, Kann BH, Bratman SV, Hope AJ, Haibe-Kains B. Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics. Cancer Res Commun. 2023 Jun;3(6):1140-1151. doi: 10.1158/2767-9764.CRC-22-0152. eCollection 2023 Jun. PubMed PMID: 37397861; PubMed Central PMCID: PMC10309070.
Karimzadeh M, Arlidge C, Rostami A, Lupien M, Bratman SV, Hoffman MM. Human papillomavirus integration transforms chromatin to drive oncogenesis. Genome Biol. 2023 Jun 27;24(1):142. doi: 10.1186/s13059-023-02926-9. PubMed PMID: 37365652; PubMed Central PMCID: PMC10294493.
Brooks PJ, Malkin EZ, De Michino S, Bratman SV. Isolation of salivary cell-free DNA for cancer detection. PLoS One. 2023;18(5):e0285214. doi: 10.1371/journal.pone.0285214. eCollection 2023. PubMed PMID: 37130100; PubMed Central PMCID: PMC10153704.
Ballal Y, Gete M, Su J, O'Sullivan B, Waldron JN, Irish J, Ringash J, Kim J, Bratman S, Cho J, Hope AJ, Hosni A, de Almeida J, Goldstein DP, Witterick I, Monteiro E, Tong L, Xu W, Hui Huang S, Hahn E. The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis. Oral Oncol. 2023 Mar;138:106332. doi: 10.1016/j.oraloncology.2023.106332. Epub 2023 Feb 3. PubMed PMID: 36780824; PubMed Central PMCID: PMC9894773.
Ul Haq S, Schmid S, Aparnathi MK, Hueniken K, Zhan LJ, Sacdalan D, Li JJN, Meti N, Patel D, Cheng D, Philip V, Tsao MS, Cabanero M, de Carvalho D, Liu G, Bratman SV, Lok BH. Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. iScience. 2022 Dec 22;25(12):105487. doi: 10.1016/j.isci.2022.105487. eCollection 2022 Dec 22. PubMed PMID: 36425756; PubMed Central PMCID: PMC9678731.
Chen S, Petricca J, Ye W, Guan J, Zeng Y, Cheng N, Gong L, Shen SY, Hua JT, Crumbaker M, Fraser M, Liu S, Bratman SV, van der Kwast T, Pugh T, Joshua AM, De Carvalho DD, Chi KN, Awadalla P, Ji G, Feng F, Wyatt AW, He HH. The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors. Nat Commun. 2022 Oct 29;13(1):6467. doi: 10.1038/s41467-022-34012-2. PubMed PMID: 36309516; PubMed Central PMCID: PMC9617856.
Malkin EZ, De Michino S, Lambie M, Gill R, Zhao Z, Rostami A, Arruda A, Minden MD, Bratman SV. Cell-free DNA topology depends on its subcellular and cellular origins in cancer. JCI Insight. 2022 Oct 24;7(20). doi: 10.1172/jci.insight.159590. PubMed PMID: 36125881; PubMed Central PMCID: PMC9714790.
Ghatasheh H, Huang SH, Su J, Xu W, Bratman SV, Cho J, Giuliani M, Hahn E, Hope A, Kim J, O'Sullivan B, Ringash J, Waldron J, Chepeha DB, Irish JC, Goldstein DP, Spreafico A, Tong L, de Almeida JR, Hosni A. Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary. Radiother Oncol. 2022 Oct;175:56-64. doi: 10.1016/j.radonc.2022.07.016. Epub 2022 Jul 26. PubMed PMID: 35905781.
Haddad G, Hueniken K, Xu MC, Bratman S, de Almeida J, Goldstein D, Huang SH, Hansen A, Hope A, Spreafico A, Xu W, Liu G. Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer. Head Neck. 2022 Oct;44(10):2181-2196. doi: 10.1002/hed.27139. Epub 2022 Jul 7. PubMed PMID: 35801270.
Wilson SL, Shen SY, Harmon L, Burgener JM, Triche T Jr, Bratman SV, De Carvalho DD, Hoffman MM. Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls. Cell Rep Methods. 2022 Sep 19;2(9):100294. doi: 10.1016/j.crmeth.2022.100294. eCollection 2022 Sep 19. PubMed PMID: 36160046; PubMed Central PMCID: PMC9499995.
Huang SH, Jacinto JCK, O'Sullivan B, Su J, Kim J, Ringash J, Spreafico A, Yu E, Perez-Ordonez B, Weinreb I, Cho J, Hope AJ, Bratman SV, Giuliani ME, Hosni A, Hahn E, Goldstein DP, Tong L, Eng L, Xu W, Waldron JN. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer. 2022 Aug 1;128(15):2908-2921. doi: 10.1002/cncr.34266. Epub 2022 May 19. PubMed PMID: 35588085.
Dmytriw AA, Ortega C, Anconina R, Metser U, Liu ZA, Liu Z, Li X, Sananmuang T, Yu E, Joshi S, Waldron J, Huang SH, Bratman S, Hope A, Veit-Haibach P. Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up. Cancers (Basel). 2022 Jun 24;14(13). doi: 10.3390/cancers14133105. PubMed PMID: 35804877; PubMed Central PMCID: PMC9264840.
Main SC, Cescon DW, Bratman SV. Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer. Cancer Drug Resist. 2022;5(3):727-748. doi: 10.20517/cdr.2022.37. eCollection 2022. Review. PubMed PMID: 36176758; PubMed Central PMCID: PMC9511796.
Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2022 Apr 15;150(8):1329-1340. doi: 10.1002/ijc.33876. Epub 2021 Dec 2. PubMed PMID: 34792199.
Id Said B, Ailles L, Karamboulas C, Meens J, Huang SH, Xu W, Keshavarzi S, Bratman SV, Cho BCJ, Giuliani M, Hahn E, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A, Hosni A. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment. JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):342-349. doi: 10.1001/jamaoto.2022.0003. PubMed PMID: 35238880; PubMed Central PMCID: PMC8895316.
Ren J, Pang W, Hueniken K, Haddad G, Hope A, Huang SH, Spreafico A, Hansen AR, Perez-Ordonez B, Goldstein DP, Bratman SV, Zhang W, Zhao Y, Xu W, de Almeida JR, Liu G. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers. Cancer. 2022 Feb 1;128(3):497-508. doi: 10.1002/cncr.33936. Epub 2021 Oct 1. PubMed PMID: 34597435.
Sanz-Garcia E, Zhao E, Bratman SV, Siu LL. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges. Sci Adv. 2022 Jan 28;8(4):eabi8618. doi: 10.1126/sciadv.abi8618. Epub 2022 Jan 26. Review. PubMed PMID: 35080978; PubMed Central PMCID: PMC8791609.
Chin O, Yu E, O'Sullivan B, Su J, Tellier A, Siu L, Waldron J, Kim J, Hansen A, Hope A, Cho J, Giuliani M, Ringash J, Spreafico A, Bratman S, Hosni A, Hahn E, Tong L, Xu W, Huang SH. Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort. Radiother Oncol. 2021 Dec;165:94-102. doi: 10.1016/j.radonc.2021.10.018. Epub 2021 Oct 27. PubMed PMID: 34718052.
Zazuli Z, de Jong C, Xu W, Vijverberg SJH, Masereeuw R, Patel D, Mirshams M, Khan K, Cheng D, Ordonez-Perez B, Huang S, Spreafico A, Hansen AR, Goldstein DP, de Almeida JR, Bratman SV, Hope A, Knox JJ, Wong RKS, Darling GE, Kitchlu A, van Haarlem SWA, van der Meer F, van Lindert ASR, Ten Heuvel A, Brouwer J, Ross CJD, Carleton BC, Egberts TCG, Herder GJM, Deneer VHM, Maitland-van der Zee AH, Liu G. Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. J Pers Med. 2021 Nov 20;11(11). doi: 10.3390/jpm11111233. PubMed PMID: 34834585; PubMed Central PMCID: PMC8623115.
Leung E, Han K, Zou J, Zhao Z, Zheng Y, Wang TT, Rostami A, Siu LL, Pugh TJ, Bratman SV. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA. Clin Cancer Res. 2021 Nov 1;27(21):5857-5868. doi: 10.1158/1078-0432.CCR-19-2384. Epub 2021 Sep 27. PubMed PMID: 34580115; PubMed Central PMCID: PMC9401563.
Muhanna N, Eu D, Chan HHL, Douglas C, Townson JL, Di Grappa MA, Mohamadi RM, Kelley SO, Bratman SV, Irish JC. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy. BMC Cancer. 2021 Oct 2;21(1):1075. doi: 10.1186/s12885-021-08791-8. PubMed PMID: 34600526; PubMed Central PMCID: PMC8487588.
Chiu K, Hosni A, Huang SH, Tong L, Xu W, Lu L, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, Irish J, Gilbert R, Gullane P, Goldstein D, O'Sullivan B, Hope A. The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer. Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e442-e449. doi: 10.1016/j.clon.2021.05.007. Epub 2021 Jul 11. PubMed PMID: 34261594.
Oliva M, Chepeha D, Araujo DV, Diaz-Mejia JJ, Olson P, Prawira A, Spreafico A, Bratman SV, Shek T, de Almeida J, R Hansen A, Hope A, Goldstein D, Weinreb I, Smith S, Perez-Ordoñez B, Irish J, Torti D, Bruce JP, Wang BX, Fortuna A, Pugh TJ, Der-Torossian H, Shazer R, Attanasio N, Au Q, Tin A, Feeney J, Sethi H, Aleshin A, Chen I, Siu L. Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study. J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003476. PubMed PMID: 34599023; PubMed Central PMCID: PMC8488751.
Rostami A, Bratman SV, Han K. Liquid Biopsy Goes Viral: Next-Generation Sequencing to Enhance HPV Detection. Clin Cancer Res. 2021 Oct 1;27(19):5158-5160. doi: 10.1158/1078-0432.CCR-21-2180. PubMed PMID: 34301747.
Gudi S, O'Sullivan B, Hosni A, Su J, Hope A, Ringash J, Hueniken K, Liu G, Tong L, Goldstein D, de Almeida J, Hansen AR, Bratman SV, Cho J, Giuliani M, Hahn E, Kim J, Xu W, Waldron J, Huang SH. Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study. Oral Oncol. 2021 Sep;120:105419. doi: 10.1016/j.oraloncology.2021.105419. Epub 2021 Jun 25. PubMed PMID: 34175612.
What would you like to do?